Abstract:Protein kinase G (PknG), a eukaryotic type serine-threonine protein kinase (STPK) in Mycobacterium tuberculosis (Mtb), is secreted into the cytosol of infected macrophages to promote intracellular survival of mycobacteria and has been considered as a promising therapeutic target for tuberculosis (TB) treatment. However, the molecular details of Mtb PknG-host intracellular interactions remain obscure. Here, we demonstrate that PknG serves as both the ubiquitin-activating enzyme (E1) and the ubiquitin ligase (E3) to promote ubiquitination and degradation of tumor necrosis factor receptor-associated factor 2 (TRAF2) and TGF–β-activated kinase 1 (TAK1), and thus inhibits the NF-κB-mediated host innate immune responses. Surprisingly, PknG promotes the attachment of ubiquitin (Ub) to ubiquitin-conjugating enzyme (E2) UbcH7 via an isopeptide bond (UbcH7 K82-Ub), instead of a usual C86-Ub thiol-ester bond, and then promotes the discharge of Ub from UbcH7 by acting as an isopeptidase before attaching Ub to its substrates TRAF2 and TAK1. These results demonstrate that Mtb PknG promotes ubiquitination of the key components of the host innate immunity by acting as an unusual ubiquitinating enzyme to suppress innate immunity. Our findings provide a potential TB treatment via targeting unconventional ubiquitinating activities of PknG. Significance Mycobacterium tuberculosis (Mtb) protein kinase G (PknG), which is critical for Mtb intracellular survival, is a promising target for tuberculosis (TB) treatment. However, the molecular mechanisms underlying PknG-host interactions remain largely unclear. Here we demonstrate that PknG serves as both the ubiquitin-activating enzyme and the ubiquitin ligase to promote the ubiquitination and degradation of tumor necrosis factor receptor-associated factor 2 (TRAF2) and TGF-β-activated kinase 1 (TAK1), thus inhibiting NF-κB signaling activation. PknG promotes the attachment of ubiquitin to ubiquitin-conjugating enzyme UbcH7 via an isopeptide bond, instead of a usual thiol-ester bond, and releases the ubiquitin from UbcH7 by acting as an isopeptidase. These findings provide important information for rational development of TB treatment via targeting unconventional ubiquitinating activity of PknG. ### Competing Interest Statement The authors have declared no competing interest.

Sclerotiorin Inhibits Protein Kinase G from Mycobacterium Tuberculosis and Impairs Mycobacterial Growth in Macrophages.

Glycogen synthase kinase 3 inhibition controls Mycobacterium tuberculosis infection

Identification of Host-Targeted Small Molecules That Restrict Intracellular Mycobacterium tuberculosis Growth

Sirtuin inhibitors reduce intracellular growth of M. tuberculosis in human macrophages via modulation of host cell immunity

Mycobacterium Tuberculosis RKIP (rv2140c) Dephosphorylates ERK/NF-κB Upstream Signaling Molecules to Subvert Macrophage Innate Immune Response.

Sirtuin inhibits <i>M</i>. <i>tuberculosis</i> -induced apoptosis in macrophage through glycogen synthase kinase-3

A Mycobacterium tuberculosis effector protein attacks host innate immunity by acting as an unusual ubiquitinating enzyme

M. tuberculosis PknG manipulates host autophagy flux to promote pathogen intracellular survival

Mycobacterium tuberculosis protein kinase G acts as an unusual ubiquitinating enzyme to impair host immunity

Predictive Binding Affinity of Plant-Derived Natural Products Towards the Protein Kinase G Enzyme of Mycobacterium tuberculosis (MtPknG)

Identification of Bostrycin Derivatives As Potential Inhibitors of Mycobacterium Tuberculosis Protein Tyrosine Phosphatase (Mptpb)

In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis

Inhibition of Mycobacterium tuberculosis MtrA response regulator by anticancer drugs via computational methods

Repurposing an Antioxidant to Kill <i>Mycobacterium tuberculosis</i> by Targeting the 50S Subunit of the Ribosome

Identification of BMVC-8C3O As a Novel Pks13 Inhibitor with Anti-Tuberculosis Activity

Discovery and Mechanistic Study of Novel Mycobacterium tuberculosis ClpP1P2 Inhibitors

PE_PGRS31-S100A9 Interaction Promotes Mycobacterial Survival in Macrophages Through the Regulation of NF-κB-TNF-α Signaling and Arachidonic Acid Metabolism.

Synergistic Lethality of a Binary Inhibitor of Mycobacterium tuberculosis KasA

Targeting PknL as a novel therapeutic strategy against Mycobacterium tuberculosis

A Novel Inhibitor Of Indole-3-Glycerol Phosphate Synthase With Activity Against Multidrug-Resistant Mycobacterium Tuberculosis

Mycobacterium Tuberculosis PE_PGRS41 Enhances the Intracellular Survival of M. Smegmatis Within Macrophages Via Blocking Innate Immunity and Inhibition of Host Defense